As differentiation markers for the UPS/MFS cluster (sarcoma cluster 4) DMRT2, ZNF217 and CDKN2A were selected for comparison with sarcoma cluster 1 (mainly DDLS samples), sarcoma cluster 2 (LMS samples) and sarcoma cluster 4 (mainly PLS samples), respectively. Here, ZNF217 is linked to sarcoma.